Hypertension (high blood pressure) — all decisions

The Board denied service connection for the cause of the Veteran's death, finding no evidence that the Veteran was exposed to herbicides during his service.

The Board granted a 30 percent evaluation for tension headaches effective September 13, 2022, but denied earlier effective dates and service connection for various conditions.

The appeal for service connection for hypertension and sleep apnea was dismissed due to a duty to assist error in the April 2025 rating decision.

The Board denied service connection for cervical strain and a compensable rating for scars post-removal of squamous cell carcinomas, while remanding several other claims including diabetes mellitus, type II, diabetic neuropathies, obstructive sleep apnea, hypertension, left knee disability, traumatic brain injury with post-concussion syndrome migraines, and left hip disability.

The Board denied a compensable evaluation for hypertension and granted an increased rating of 20 percent for lumbar spine degenerative disc disease from April 13, 2022. The effective date for the right lower extremity radiculopathy was also granted as May 10, 2016.

The Board remands the issue of entitlement to a total disability rating based on individual unemployability (TDIU) for further development and readjudication.

The Board denied service connection for hypertension as it is not etiologically related to the Veteran's active duty service.

The Board denied service connection for pheochromocytoma, hypertension (HTN), heart condition, and diabetes mellitus, type II due to a lack of evidence linking these conditions to the Veteran's military service.

The Veteran's hypertension did not meet the criteria for a compensable rating, and several claims were remanded for further development.

The Board granted service connection for lumbar spine disability, as secondary to the Veteran's service-connected left foot crush injury, and sciatic radiculopathy of both lower extremities, also secondary to the newly service-connected lumbar spine disability. The Board denied an initial rating in excess of 70 percent for depressive disorder with unspecified anxiety disorder and a compensable rating for allergic rhinitis.

The appeal was granted for the severance of service connection for hypertension and entitlement to service connection for a heart disability (claimed as cardiomyopathy) associated with hypertension. The claim for an initial compensable rating for hypertension was remanded.

The Board granted an initial evaluation of 20 percent for left and right ankle strains, denied a compensable evaluation for bilateral hearing loss, and remanded claims for hypertension and gout.

The appeal for an initial rating in excess of 70 percent, effective March 18, 2021, for post-traumatic stress disorder (PTSD) was withdrawn by the Veteran prior to the Board's decision and thus is dismissed.

The Board remands the issue of entitlement to service connection for hypertension, to include as secondary to a service-connected major depressive disorder, due to a pre-decisional duty to assist error.

The Veteran is granted a total disability rating based on individual unemployability due to his service-connected disabilities, but the claims for an increased evaluation in excess of 10 percent for hypertension and for service connection for sleep apnea are denied.

The Board granted service connection for an acquired psychiatric disorder but remanded the claims for hypertension and erectile dysfunction.

The Board dismissed the appeals for an earlier effective date and higher ratings, as well as denied service connection for various conditions.

The Board denied service connection for hypertension and remanded the claims for bilateral tinnitus, right knee osteoarthritis, and left knee osteoarthritis due to inadequate medical evidence.

The Board denied the Veteran's claim for a total disability rating based upon individual unemployability due to service-connected disabilities.

The Board granted a disability rating of 10 percent for hypertension, effective June 3, 2021.